Literature DB >> 17662623

H9c2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart.

Beshay N M Zordoky1, Ayman O S El-Kadi.   

Abstract

INTRODUCTION: Recent studies demonstrated that cultured primary cardiomyocytes are a valuable tool for studying the metabolic capacity of the heart. However, a major limitation for isolated cardiomyocytes is that they are rather fragile and difficult to isolate. Therefore, there is an urgent need for an in vitro cell line model.
METHODS: Expression of different cytochrome P450 (CYP) genes were examined in a rat H9c2 cell line in comparison with that of rat heart. RNAs from H9c2 cells, rat heart as well as rat liver were isolated and CYP mRNA expression was determined by reverse transcription-polymerase chain reaction.
RESULTS: Our results showed that CYP1A1 and 1B1 are constitutively expressed in both H9c2 cells and the heart. CYP1A1 was induced by beta-naphthoflavone in H9c2 cells and the heart, whereas CYP1B1 was only induced in the heart. CYP2B1, 2B2, 2E1 and 2J3 were expressed in H9c2 cells and the heart at a comparable level but significantly lower than that detected in the liver. Expression of CYP2C11, 2C13, and 2C23 appeared to be greater in the cell line than in heart. On the other hand, CYP2A1, 3A1, and 3A2 were not expressed either in H9c2 cells or in the heart. DISCUSSION: Our findings provide the first evidence for the expression of multiple CYPs in H9c2 cells at comparable levels to those expressed in the rat heart. Therefore, this cell line offers a valuable in vitro model to study the metabolic capacity of the heart.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17662623     DOI: 10.1016/j.vascn.2007.06.001

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  31 in total

1.  Contrast agent-free sonoporation: The use of an ultrasonic standing wave microfluidic system for the delivery of pharmaceutical agents.

Authors:  Dario Carugo; Dyan N Ankrett; Peter Glynne-Jones; Lorenzo Capretto; Rosemary J Boltryk; Xunli Zhang; Paul A Townsend; Martyn Hill
Journal:  Biomicrofluidics       Date:  2011-11-15       Impact factor: 2.800

Review 2.  Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes.

Authors:  Thomas Force; Kyle L Kolaja
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

3.  Celastrol protects ischaemic myocardium through a heat shock response with up-regulation of haeme oxygenase-1.

Authors:  S Der Sarkissian; J-F Cailhier; M Borie; L-M Stevens; L Gaboury; S Mansour; P Hamet; N Noiseux
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

4.  Anti-hypotensive drug induced cardiotoxicity: an in vitro study.

Authors:  Aditi Jain; Vibha Rani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-01-10       Impact factor: 2.416

5.  Mode of treatment governs curcumin response on doxorubicin-induced toxicity in cardiomyoblasts.

Authors:  Aditi Jain; Vibha Rani
Journal:  Mol Cell Biochem       Date:  2017-09-19       Impact factor: 3.396

6.  Cell Death Persists in Rapid Extrusion of Lysis-Resistant Coated Cardiac Myoblasts.

Authors:  Calvin F Cahall; Aman Preet Kaur; Kara A Davis; Jonathan T Pham; Hainsworth Y Shin; Brad J Berron
Journal:  Bioprinting       Date:  2019-12-25

7.  TLR4 regulates cardiac lipid accumulation and diabetic heart disease in the nonobese diabetic mouse model of type 1 diabetes.

Authors:  Baojun Dong; Dake Qi; Long Yang; Yan Huang; Xiaoyan Xiao; Ningwen Tai; Li Wen; F Susan Wong
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-07-27       Impact factor: 4.733

8.  Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy.

Authors:  Hassan N Althurwi; Mandy M Y Tse; Ghada Abdelhamid; Beshay N M Zordoky; Bruce D Hammock; Ayman O S El-Kadi
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

9.  Curcumin-mediated effects on anti-diabetic drug-induced cardiotoxicity.

Authors:  Aditi Jain; Vibha Rani
Journal:  3 Biotech       Date:  2018-09-07       Impact factor: 2.406

10.  Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator.

Authors:  Evangelia Vlachodimitropoulou; Yu-Lin Chen; Maciej Garbowski; Pimpisid Koonyosying; Bethan Psaila; Martha Sola-Visner; Nichola Cooper; Robert Hider; John Porter
Journal:  Blood       Date:  2017-09-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.